Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Bander

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding proteinN E Tolkoff-Rubin, R E Thompson, D J Piper, et al.
Transplantation|May 1, 1986
Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding proteinN E Tolkoff-Rubin, A B Cosimi, F L Delmonico, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Mechanisms of apoptosis in T cells from patients with renal cell carcinomaR G Uzzo, P Rayman, V Kolenko, et al.
Cancer Research|November 21, 2000
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancerM R McDevitt, E Barendswaard, D Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinomaC R Divgi, N H Bander, A M Scott, et al.
Skin Health and Disease|September 20, 2021
Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinomaM K Ramirez-Fort, B Meier-Schiesser, K Lachance, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1987
Diagnosis of renal proximal tubular injury by urinary immunoassay for a proximal tubular antigen, the adenosine deaminase binding proteinN E Tolkoff-Rubin, R E Thompson, D J Piper, et al.
Transplantation|May 1, 1986
Diagnosis of tubular injury in renal transplant patients by a urinary assay for a proximal tubular antigen, the adenosine-deaminase-binding proteinN E Tolkoff-Rubin, A B Cosimi, F L Delmonico, et al.
Cancer|August 3, 1999
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9J M McKiernan, R Buttyan, N H Bander, et al.
Molecular Urology|November 4, 2000
Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapyM C Gong, S S Chang, F Watt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Mechanisms of apoptosis in T cells from patients with renal cell carcinomaR G Uzzo, P Rayman, V Kolenko, et al.
Cancer Research|November 21, 2000
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancerM R McDevitt, E Barendswaard, D Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinomaC R Divgi, N H Bander, A M Scott, et al.
Skin Health and Disease|September 20, 2021
Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinomaM K Ramirez-Fort, B Meier-Schiesser, K Lachance, et al.
Pageof 8